Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PCDHGB6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TMEM204 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRNA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABCB11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506348 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CALML6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MARCH7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2D4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC101928708 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOTAIRM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC25A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSTPIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZIC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FANCM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDHR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIMK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on